NCT06125977
Impact of Non-Exudative Type 1 MNV on AMD Progression No drug interventions Not Available Not Available active_not_recruiting NCT03038880
Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration No drug interventions treatment 2 completed NCT01162746
Comparison of Ranibizumab Monotherapy and Ranibizumab Combination Therapies in Recurrent or Persistent Choroidal Neovascularization Secondary to Age-related Macular Degeneration No drug interventions treatment 2 completed NCT00260403
TTT Versus PDT for Treatment of Choroidal Neovascularization in Age-Related Macular Degeneration No drug interventions treatment 2 / 3 unknown_status NCT00417703
Intraocular Pressure Immediately Following Intravitreous Injection of Ranibizumab No drug interventions Not Available Not Available completed NCT01570790
Combretastatin A4 Phosphate in Patients With Neovascular Age-Related Macular Degeneration No drug interventions treatment 1 / 2 completed NCT00331864
SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration No drug interventions treatment 3 completed NCT00492284
Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL) No drug interventions treatment 2 completed NCT04488887
OCTA Metrics Repeatability and Reproducibility in Different Disorders No drug interventions Not Available Not Available unknown_status NCT02260687
Special Drug Use Investigation of EYLEA for Myopic Choroidal Neovascularization Not Available Not Available completed NCT01628354
Study to Investigate the Safety and Efficacy of Ranibizumab in Patients With Choroidal Neovascularisation Due to Causes Other Than Age Related Macular Degeneration treatment 4 completed NCT00395551
Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization That Was Caused Other Than by Age-Related Macular Degeneration. No drug interventions treatment 1 completed NCT02015351
Intravitreal Bevacizumab for the Treatment of CNV in VKH Disease - A Prospective Study treatment Not Available completed NCT00436553
Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization No drug interventions treatment 3 completed NCT00426998
Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMD No drug interventions treatment 2 completed NCT00570193
Photodynamic and Pharmacologic Treatment of CNV No drug interventions treatment 1 / 2 completed NCT04782271
Safety, Tolerability and Pharmacokinetic Profile of SYL1801 Eye Drops No drug interventions treatment 1 completed NCT03042871
Dosing Strategy of Intravitreal Ranibizumab for Pathological Myopia Choroidal Neovascularization treatment 4 completed NCT01880788
Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD No drug interventions Not Available Not Available completed NCT04075188
Treatment of Polypoidal Choroidal Vasculopathy in Pachychoroid treatment Not Available completed NCT00008515
Fluocinolone Implant to Treat Macular Degeneration treatment 1 completed NCT02308215
Retinal Therapy Guided by 3D OCT Image Analysis No drug interventions Not Available Not Available completed NCT00102115
Study of Talaporfin Sodium Photodynamic Therapy to Treat Advanced Age Related Macular Disease treatment 1 terminated NCT01256632
Evaluation of the Effect of Vitreous Composition Determined by Ultrasound and Optical Coherence Tomography (OCT) on Ranibizumab Therapy No drug interventions Not Available Not Available completed NCT01136252
Intravitreal Adalimumab in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration No drug interventions treatment 2 completed NCT00251459
A Study to Evaluate Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) treatment 3 completed NCT05494775
Effect of Corona Virus on Intravitreal Injections No drug interventions treatment Not Available unknown_status NCT01531842
A Research Study to Evaluate the Effects of Repeated Intravitreal Injections on Bacteria Around the Eye No drug interventions supportive_care Not Available unknown_status NCT01666236
Triple Treatment for Detachment of Retinal Pigment Epithelium Secondary to Polypoidal Choroidal Vasculopathy No drug interventions treatment 4 withdrawn NCT00021736
Phase II/III Study of Anti-VEGF in Neovascular AMD treatment 2 / 3 completed NCT00407719
Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD) No drug interventions treatment 1 completed NCT03024424
Value of Genetic Counseling and Testing for Patients Who Would Like to Know More About Their Personal Risk of AMD No drug interventions prevention Not Available completed NCT01908816
An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases. treatment 3 completed NCT00370786
Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV) No drug interventions treatment 3 completed NCT01948830
Randomized Study for Efficacy and Safety of Ranibizumab 0.5mg in Treat-extend and Monthly Regimens in Patients With nAMD supportive_care 3 completed NCT00509548
Open-Label, Pilot Study of TG100801 in Patients With Choroidal Neovascularization Due to AMD No drug interventions treatment 2 terminated NCT00272766
Macugen for Histoplasmosis treatment Not Available terminated NCT00599820
Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid Streaks No drug interventions treatment 3 terminated NCT02307682
Efficacy and Safety of RTH258 Versus Aflibercept - Study 1 treatment 3 completed NCT03452527
Open-Label Study of Intravitreal ICON-1 in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD) treatment 2 terminated NCT02857894
Genetic Factors of Idiopathic Polypoidal Vasculopathies in the ATM Gene (Ataxia Telangiectasia Mutated) No drug interventions Not Available Not Available terminated NCT00568191
Stratus Versus Cirrus OCT in AMD No drug interventions Not Available Not Available unknown_status NCT00712491
Phase 1/2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Age-Related Macular Degeneration No drug interventions treatment 1 / 2 terminated NCT01256580
Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD No drug interventions treatment Not Available withdrawn NCT02358889
Study Evaluating Intravitreal hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration No drug interventions treatment 2 completed NCT00406744
Efficacy of Retreatments With Intravitreal Bevacizumab No drug interventions treatment 3 terminated NCT01298440
Bevacizumab Effect on Blood Velocity No drug interventions Not Available Not Available completed NCT00417846
Age-related Macular Degeneration: Detection of Onset of New Choroidal Neovascularization (AMD DOC Study) No drug interventions Not Available Not Available completed NCT00813514
Does Vascular Endothelial Growth Factor (VEGF) or Complement Factor H Gene Polymorphism Play a Role in the Treatment Success With VEGF Inhibitors in Patients With Choroidal NeoVascularization (CNV)? No drug interventions diagnostic Not Available withdrawn NCT03409250
SD-OCT-guided Intravitreal Ranibizumab Treatment in Choroidal Neovascularization Due to Myopia No drug interventions treatment 4 completed NCT00967850
Efficacy and Safety of Intravitreal Bevacizumab in the Treatment of Choroidal Neovascular Membranes Associated to High Myopia No drug interventions treatment 3 completed NCT00855608
Intravitreal Adalimumab in Refractory Diabetic Retinopathy, Choroidal Neovascularization or Uveitis: A Pilot Study No drug interventions treatment 1 unknown_status NCT04439708
Biomarkers and Choroidal Neovascularization No drug interventions Not Available Not Available unknown_status NCT05662943
Outcomes of Tolerating Subretinal Fluid in Type 1 MNV and PCV No drug interventions Not Available Not Available completed NCT02484690
A Proof-of-Concept Study of Faricimab (RO6867461) in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) No drug interventions treatment 2 completed NCT02486484
Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection No drug interventions treatment 2 unknown_status NCT03838679
Imaging of the Angiofibrotic Switch in Neovascular AMD No drug interventions Not Available Not Available unknown_status NCT00100087
Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System No drug interventions treatment 1 / 2 unknown_status NCT00417833
Multifocal Electrophysiologic Findings After Intravitreal Bevacizumab(Avastin)Treatment No drug interventions Not Available 2 / 3 terminated NCT00304954
Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular Degeneration No drug interventions treatment 2 completed NCT02821247
Prospective Observational Study to Assess Effectiveness of Intravitreal Aflibercept in Patients With Wet Macular Degeneration in Greece No drug interventions Not Available Not Available completed NCT02434328
Efficacy and Safety of RTH258 Versus Aflibercept - Study 2 No drug interventions treatment 3 completed NCT00775411
Safety and Efficacy of a New Therapy as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) in Subjects With Wet Age-Related Macular Degeneration (AMD) No drug interventions treatment 2 completed NCT00604071
Sensitivity of the Home Macular Perimeter (HMP) No drug interventions Not Available Not Available completed NCT00470678
EXTEND III - Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD) No drug interventions treatment 3 completed NCT01336907
Comparison Between Home Macular Perimeter and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV) No drug interventions Not Available Not Available withdrawn NCT03105609
Enhancing the Lucentis (Ranibizumab) Management of Choroidal Neovascular Membranes With Hyperspectral Imaging No drug interventions Not Available Not Available terminated NCT01021956
Safety and Preliminary Efficacy Study of WST11 (Stakel®)-Mediated VTP Therapy in Subjects With CNV Associated With AMD No drug interventions treatment 2 terminated NCT00403156
Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration No drug interventions treatment 1 withdrawn NCT00001615
Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular Degeneration No drug interventions treatment 1 completed NCT00766337
Phase 2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Combination With Lucentis® in Patients With Age-Related Macular Degeneration No drug interventions treatment 2 terminated NCT03793400
Long-term Outcome of Punctate Inner Choroidopathy or Multifocal Choroiditis With Active Choroidal Neovascularization Managed With Anti-vascular Endothelial Growth Factor No drug interventions Not Available Not Available completed NCT00473642
Reduced Fluence Photodynamic Therapy (PDT) With Visudyne in Combination With Lucentis for Age-Related Macular Degeneration No drug interventions treatment 4 completed NCT01445899
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME) No drug interventions treatment 2 completed NCT04455399
Time Efficiency Comparison of Two IntraVitreal Injection Techniques No drug interventions treatment Not Available completed NCT06243406
Study on the Biomarkers of Anti-VEGF Treatment for Choroidal Neovascularization No drug interventions Not Available Not Available not_yet_recruiting NCT00511706
Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment in Patients With Age-Related Macular Degeneration (AMD) No drug interventions treatment 2 completed NCT01423149
Safety and Efficacy Study of Combretastatin A4 Phosphate to Treat Patients With Choroidal Neovascularization Secondary to Pathologic Myopia No drug interventions treatment 2 completed NCT02934841
Conbercept in Choroidal Neovascularization Secondary to Uveitis No drug interventions treatment 2 unknown_status NCT00433017
Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD) No drug interventions treatment 2 / 3 terminated NCT00000158
Macular Photocoagulation Study (MPS) No drug interventions treatment 3 unknown_status NCT01025063
Use of Spectral OCT in Combination Therapy No drug interventions Not Available Not Available completed NCT00305630
Neovascular Age Related Macular Degeneration (AMD), Periocular Corticosteroids, and Photodynamic Therapy (PDT) No drug interventions treatment 2 / 3 completed NCT00510965
Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE) No drug interventions treatment 2 completed NCT00533520
Evaluation of Dosing Interval of Higher Doses of Ranibizumab No drug interventions treatment 4 completed NCT01578720
Intravitreal Aflibercept Injection (IAI) for Presumed Ocular Histoplasmosis Syndrome No drug interventions treatment 1 completed NCT05055973
OCTA Insights in CNVM, Morphological Characteristics and Correlation With Structural OCT. No drug interventions Not Available Not Available unknown_status NCT01334294
Home Vision Monitoring Using the ForeseeHome Device Following Treatment of Neovascular Age Related Macular Degeneration No drug interventions Not Available Not Available completed NCT00429962
Study Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNV No drug interventions treatment 3 completed NCT00242580
A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib No drug interventions treatment 3 completed NCT03393767
Time Course of Activity Signs at SD-OCT High Frequency Intravitreal Ranibizumab Treatment in CNV Due to AMD No drug interventions treatment 4 completed NCT00363168
Ranibizumab in Hemorrhagic Choroidal Neovascularization Trial No drug interventions treatment 1 completed NCT00729846
Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT) No drug interventions treatment 2 completed NCT01175395
20089 TA+Lucentis Combo Intravitreal Injections for Treatment of Neovascular Age-related Macular Degeneration (AMD) No drug interventions treatment 1 / 2 completed NCT00363714
A Dose Escalation Trial of an Intravitreal Injection of Sirna-027 in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) No drug interventions treatment 1 / 2 completed NCT00406250
Intravitreal Bevacizumab in Agioid Streaks No drug interventions treatment 1 completed NCT02599064
Evaluating RXI-109 to Reduce the Progression of Subretinal Fibrosis in Subjects With NVAMD No drug interventions treatment 1 / 2 unknown_status NCT01122511
Safety and Efficacy of Dexamethasone as Adjunctive Therapy to Ranibizumab in Subjects With Choroidal Neovascularization and Age-Related Macular Degeneration No drug interventions treatment 2 terminated NCT00930189
Comparative Study With Photodynamic Therapy And Triamcinolone Versus Photodynamic Therapy, Triamcinolone And Ranibizumab In Patients With Subfoveal Choroidal Neovascularization No drug interventions treatment 2 / 3 withdrawn NCT00327470
An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMD No drug interventions treatment 4 terminated NCT00902785
A Study Of Early Markers Of Choroidal Neovascularization No drug interventions Not Available Not Available terminated NCT01840410
Assess the Efficacy/Safety of Intravitreal Ranibizumab in Patients With Vision Loss Due to Choroidal Neovascularization. No drug interventions treatment 3 completed NCT00504959
Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration No drug interventions treatment 4 completed